NICE not recommending teduglutide for SBS

NICE not recommending teduglutide for SBS PharmacoEconomics & Outcomes News 792, p34 - 2 Dec 2017 NICE not recommending teduglutide for SBS In draft guidance, the UK National Institute for Health and Care Excellence (NICE) has not recommended teduglutide (Revestive) for the treatment of short bowel syndrome (SBS) within the NHS, reported Selina McKee in PharmaTimes. NICE’s appraisal committee found that although teduglutide reduces the requirement for intravenous nutrition in patients with short bowel syndrome, it does not eliminate the need. Moreover, the estimated incremental cost- effectiveness ratio for teduglutide was £193 549 per QALY gained in adults, which exceeded NICE’s willingness-to-pay threshold for NHS funding. * National Health Service McKee S. NICE turns down Shire’s Revestive for bowel condition Pharma Times : 14 Nov 2017. Available from: URL: nice_turns_down_shires_revestive_for_bowel_condition_1211408 803283335 1173-5503/17/0792-0001/$14.95 Adis © 2017 Springer International Publishing AG. All rights reserved PharmacoEconomics & Outcomes News 2 Dec 2017 No. 792 PharmacoEconomics & Outcomes News Springer Journals

NICE not recommending teduglutide for SBS

1 page

Loading next page...
1 Page
Springer International Publishing
Copyright © 2017 by Springer International Publishing AG, part of Springer Nature
Medicine & Public Health; Pharmacoeconomics and Health Outcomes; Quality of Life Research; Health Economics; Public Health
Publisher site
See Article on Publisher Site

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.

DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches


Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.



billed annually
Start Free Trial

14-day Free Trial